SCHEMBL7846927

SCHEMBL7846927

O=C(Nc1ccc2c(c1)S(=O)(=O)c1cc(NC(=O)c3ccc(Cl)cc3)ccc1-2)c1ccc(Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.69
CA2 P00918 6/20 0.69
CA9 Q16790 6/20 0.69
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
MAPT P10636 1/20 0.53
MAP4K4 O95819 2/20 0.52
CLK2 P49760 2/20 0.52
DYRK1A Q13627 2/20 0.52
CLK4 Q9HAZ1 2/20 0.52
ROCK2 O75116 1/20 0.52
PRKD3 O94806 1/20 0.52
RPS6KB1 P23443 1/20 0.52
ROCK1 Q13464 1/20 0.52
PRKG1 Q13976 1/20 0.52
PRKD2 Q9BZL6 1/20 0.52
SGK2 Q9HBY8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4869345 0.84 CA12 (0.68) CA12CA2CA9NPC1RAB9A
SCHEMBL25970455 0.80 NPC1 (0.63) CA12CA2CA9NPC1RAB9A
SCHEMBL22580596 0.79 NPC1 (0.55) CA12CA2CA9NPC1RAB9A
SCHEMBL10939703 0.78 NPC1 (0.76) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL611657 0.78 NPC1 (0.76) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL9767723 0.78 NPC1 (0.76) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL2681347 0.76 NPC1 (0.80) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL6263607 0.75 RXFP1 (0.75) CA12CA2CA9KMT2AMEN1
SCHEMBL7396444 0.74 NPC1 (0.65) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL4874085 0.73 CASP3 (0.52) NPC1RAB9AKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608066-B1 Treating mammal susceptible to, suffering from, suspected of having or recovering from disease impacted by tissue factor, such as cardiovascular, blood coagulation, cell proliferation or immune disorders, atherosclerosis, inflammation or cancer SUNOL MOLECULAR CORPORATION 2003-08-19 US disclosed
US-6608066-B1 Treating mammal susceptible to, suffering from, suspected of having or recovering from disease impacted by tissue factor, such as cardiovascular, blood coagulation, cell proliferation or immune disorders, atherosclerosis, inflammation or cancer SUNOL MOLECULAR CORPORATION 2003-08-19 US disclosed